NAGE · Niagen Bioscience, Inc. · Proposed Sales
$2.50
+0.06 (+2.46%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$193.07M
Shares
79.13M
Volume · Oct 27
473.48K
Avg daily vol (3M)
546.87K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
17 filings
16 filers
Visit website
Investor relations